New diabetes clinical trial: Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes

Published on: April 28, 2023 at 11:00AM
Condition:   Type 2 Diabetes
Interventions:   Drug: THDB0206 Injection;   Drug: Insulin Lispro Injection
Sponsor:   Tonghua Dongbao Pharmaceutical Co.,Ltd
Recruiting
https://ift.tt/gO9mIpe